Brevan Howard Capital Management LP Relay Therapeutics, Inc. Transaction History

Brevan Howard Capital Management LP

  • $13.9 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.23 - $9.51 $33,617 - $51,315
-5,396 Reduced 17.01%
26,330 $186,000
Q2 2024

Aug 14, 2024
BUY
$5.9 - $8.02 $39,046 - $53,076
6,618 Added 26.36%
31,726 $206,000
Q1 2024

May 15, 2024
BUY
$7.5 - $12.07 $188,310 - $303,053
25,108 New
25,108 $208,000

Others Institutions Holding RLAY

# of Institutions
212
Shares Held
159M
Call Options Held
100K
Put Options Held
26.8K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $323M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email